These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22659091)

  • 1. Genetic susceptibility to teratogens: state of the art.
    Cassina M; Salviati L; Di Gianantonio E; Clementi M
    Reprod Toxicol; 2012 Sep; 34(2):186-91. PubMed ID: 22659091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of susceptibility to teratogen induced birth defects.
    Wlodarczyk BJ; Palacios AM; Chapa CJ; Zhu H; George TM; Finnell RH
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):215-26. PubMed ID: 21766441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal effects on ethanol teratogenesis in a cross between A/J and C57BL/6J mice.
    Gilliam D; Valdez N; Branson S; Dixon A; Downing C
    Alcohol; 2011 Aug; 45(5):441-9. PubMed ID: 21641750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on new developments in the study of human teratogens.
    Shepard TH; Brent RL; Friedman JM; Jones KL; Miller RK; Moore CA; Polifka JE
    Teratology; 2002 Apr; 65(4):153-61. PubMed ID: 11948561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratology of retinoids.
    Collins MD; Mao GE
    Annu Rev Pharmacol Toxicol; 1999; 39():399-430. PubMed ID: 10331090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
    Wells PG; Lee CJ; McCallum GP; Perstin J; Harper PA
    Handb Exp Pharmacol; 2010; (196):131-62. PubMed ID: 20020262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratogens and teratogenesis: general principles of clinical teratology.
    Frias JL; Thomas IT
    Ann Clin Lab Sci; 1988; 18(2):174-9. PubMed ID: 3289471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
    Liu L; Wells PG
    Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The murine Ah locus: in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism.
    Shum S; Jensen NM; Nebert DW
    Teratology; 1979 Dec; 20(3):365-76. PubMed ID: 542892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice.
    Hall JL; Harris MJ; Juriloff DM
    Teratology; 1997 May; 55(5):306-13. PubMed ID: 9261924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogen update: toluene.
    Wilkins-Haug L
    Teratology; 1997 Feb; 55(2):145-51. PubMed ID: 9143096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A genetically defined model for testing teratogenicity in vivo].
    Oksa A; Spálová I
    Sb Lek; 1988 Jun; 90(6):161-6. PubMed ID: 3261883
    [No Abstract]   [Full Text] [Related]  

  • 17. Placental improvement and reduced distal limb defects by maternal interferon-gamma injection in methylnitrosourea-exposed mice.
    Laudermilch CL; Holladay SD; Sponenberg DP; Saunders GK; Ward DL; Prater MR
    Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):597-604. PubMed ID: 16080182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the genetic background on the interaction of retinoic acid with Lx mutation of the rat.
    Bíla V; Kren V; Liska F
    Folia Biol (Praha); 2000; 46(6):264-72. PubMed ID: 11140860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.